Effects of one single-dose methylphenidate compared to one single-dose placebo on QbTest performance in adults with untreated ADHD: a randomized controlled trial.

Background: Treatment of adults with attention-deficit/hyperactivity disorder (ADHD) primary involves methylphenidate (MPH). Earlier studies have identified placebo responders to increase toward the end of the treatment periods. However, little is known about the immediate effects of placebo on the core symptoms of ADHD in adults.

Contrasting expectancy effects with objective measures in adults with untreated ADHD during QbTest.

Expectancy has been associated with neuropsychological assessments and cognitive performance. However, little is known about the effects of expectations in clinical assessments during drug trials with continuous performance tests (CPTs). In a randomized, double-blind study with cross-over design, we examined if the participants' self-reported expectations changed after one-single dose immediate release methylphenidate (MPH) and after one-single dose placebo during the QbTest.

Do enzymes change the nature of transition states? Mapping the transition state for general acid-base catalysis of a serine protease.

The properties of the transition state for serine protease-catalyzed hydrolysis of an amide bond were determined for a series of subtilisin variants from Bacillus lentus. There is no significant change in the structure of the enzyme upon introduction of charged mutations S156E/S166D, suggesting that changes in catalytic activity reflect global properties of the enzyme. The effect of charged mutations on the pK(a) of the active site histidine-64 N(epsilon)(2)-H was correlated with changes in the second-order rate constant k(cat)/K(m) for hydrolysis of tetrapeptide anilides at low ionic strength with a Brønsted slope alpha = 1.

Factors that influence outcomes of hyperopic laser in situ keratomileusis.

Purpose: To analyze the influence of preoperative corneal curvature, postoperative keratometric power, and the amount of correction on the outcomes of hyperopic laser in situ keratomileusis (LASIK).

Setting: Clínica Baviera, Instituto Oftalmológico Europeo, Madrid, Spain.

Methods: In this retrospective study, the records of 376 eyes that had LASIK for hyperopia using the Moria LSK-One microkeratome and the Technolas-Keracor 217C excimer laser were reviewed.